Clinicopathological Role of Mir-30A-5p in Hepatocellular Carcinoma Tissues and Prediction of Its Function with Bioinformatics Analysis

Wen-Ting Huang,Zu-xuan Chen,Rong-quan He,Yu-zhuang Wu,Shu-ya Yin,Xiao-na Liang,Gang Chen,Hong Yang,Zhi-gang Peng,Li-hua Yang
DOI: https://doi.org/10.2147/ott.s111431
IF: 4
2016-01-01
OncoTargets and Therapy
Abstract:Background: It has been reported that deregulation or dysfunction of microRNAs (miRNAs) plays an essential part in the hepatocarcinogenesis. However, the contribution and mechanism of microRNA-30a-5p (miR-30a-5p) in hepatocellular carcinoma (HCC) remains largely unknown. Therefore, our aim was to investigate the clinicopathological role of miR-30a-5p in HCC tissues and explore its potential pathways in this study.Methods: The expression of miR-30a-5p was measured in 95 HCC and adjacent noncancer tissues by real-time reverse transcription quantitative polymerase chain reaction. The relationship between miR-30a-5p expression levels and clinicopathological parameters was also analyzed. Furthermore, the potential target genes of miR-30a-5p were collected via online prediction and literature searching. Gene ontology and pathway enrichment analyses were used to identify the possible function of miR-30a-5p in HCC.Results: Compared with adjacent noncancer tissues (2.23 +/- 0.77), expression level of miR-30a-5p was significantly lower in HCC tissues (1.26 +/- 0.66, P<0.001). MiR-30a-5p expression was evidently correlated with tumor nodes, metastasis, tumor-node-metastasis stage, portal vein tumor embolus, vascular invasion, and status of tumor capsule (all P<0.05). A total of 878 genes were finally used for the biological informatics analyses. These prospective target genes were highly enriched in various key pathways, for instance, Ubiquitin-mediated proteolysis, Axon guidance, Neurotrophin signaling pathway, Amyotrophic lateral sclerosis, and ErbB signaling pathway.Conclusion: In conclusion, this study clarifies that the downregulation of miRNA-30a-5p might play a vital part in the incidence and progression of HCC via targeting various prospective genes and pathways. Future validation is required to further explore the prospective molecular mechanism of miR-30a-5p in HCC.
What problem does this paper attempt to address?